Sincerity Applied Materials Holdings Corp.

SINC
About the company

Sincerity Applied Materials Holdings Corp. provides advanced nano-engineered glass materials and water treatment chemicals in Australia and internationally. The company offers chemicals and coatings, water-soluble packed household chemicals, and cellulose films, as well as product engineering solutions.

Country: AustraliaPrice: $1.00Market Cap: $80.8M

Investment snapshot

6%positive consensus
Scored 1d ago

Positive

1

BUY / PASS

Neutral / negative

1 / 14

NEUTRAL / FAIL

Median fair value

$0.15

-85.0% vs price

Models with upside

0 / 17

Positive margin of safety

Key risk

No clean pass — all 16 investors flag at least one profitability criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILFAIL · Rank #2452 (Top 79.2%)PASSFAILFAILFAILFAILFAILFAILFAILFAILFAILFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/AN/AN/AN/AN/A-566.7%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Financial Basis

Annual history · FY 2021

Latest source filing: 2022-03-30

Score computed: 2026-11-14

Annual history · FY 2021

Latest source filing: 2022-03-30

Score computed: 2026-11-14

Annual history · FY 2021

Latest source filing: 2022-03-30

Score computed: 2026-11-14

Annual history · FY 2021

Latest source filing: 2022-03-30

Score computed: 2026-11-14

Annual history · FY 2021

Latest source filing: 2022-03-30

Score computed: 2026-11-14

Annual history · FY 2021 · Market data at 2026-11-01

Latest source filing: 2022-03-30

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2021

Latest source filing: 2022-03-30

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2021

Latest source filing: 2022-03-30

Score computed: 2026-11-14

Annual history · FY 2021 · Qualitative assessment

Latest source filing: 2022-03-30

Score computed: 2026-11-14

Annual history · FY 2021 · Qualitative assessment

Latest source filing: 2022-03-30

Score computed: 2026-11-14

Annual history · FY 2021 · Market data at 2026-11-01

Latest source filing: 2022-03-30

Score computed: 2026-11-14

Annual history · FY 2021 · Price history 2025-01-01–2026-11-01

Latest source filing: 2022-03-30

Score computed: 2026-11-14

Annual history · FY 2021 · Qualitative assessment

Latest source filing: 2022-03-30

Score computed: 2026-11-14

Annual history · FY 2021 · Price history 2025-01-01–2026-11-01

Latest source filing: 2022-03-30

Score computed: 2026-11-14

Annual history · FY 2021

Latest source filing: 2022-03-30

Score computed: 2026-11-14

Annual history · FY 2021

Latest source filing: 2022-03-30

Score computed: 2026-11-14

Annual history · FY 2021 · Price history 2025-01-01–2026-11-01

Latest source filing: 2022-03-30

Score computed: 2026-11-14

Where It Passes

    Where It Falls Short

    • Profitability0% pass✓ 4✗ 31▾

      No clean pass — all 16 investors flag at least one profitability criterion

      Positive EPS (10 years)1/11 years positive
      ✗GrahamPositive EPS every year for 10 years
      EPS Growth (3-yr avg, 10-yr window)
      ✗Graham>= 33% growth
      Net Income Positive (10+ years)3/11 years positive
      ✗BuffettPositive every year for 10+ years
      ROE (up to 5-year arithmetic mean)2548.0%
      ✓Buffett> 15% arithmetic mean (app rule)
      Operating Margin (10-yr trend)-138.6% (latest)
      ✓BuffettStable or rising over 10 years
      Free Cash Flow Proxy$-0.1M
      ✗BuffettPositive and growing
      Earnings Variance (10-yr CoV)
      ✗BuffettCoV < 0.3
      Retained Earnings Effectiveness
      ✗Buffett$1 retained -> > $1 market value created
      Basic earnings-growth PEG (dividends excluded)
      ✗Lynch< 1.0 (ideally < 0.5)
      3-5 Year EPS CAGR
      ✗Lynch15-30% (Fast Grower); > 0% to pass
      ROE-120.6%
      ✗Lynch> 15%
      EBIT / Enterprise Value-0.1%
      ✗Greenblatt> 10%
      Earnings Yield + ROC AssessmentEY=-0.1%, ROC=-42557.6%
      ✗GreenblattBoth EY > 10% and ROC > 25%
      Net Income / Total Assets-8.60%
      ✗PiotroskiROA > 0
      ROA Change YoY10.90% -> -8.60% (delta: -19.50%)
      ✗PiotroskiCurrent ROA > Prior ROA
      (CFO / Total Assets) vs ROACFO/Assets=5.00%, ROA=-8.60%
      ✓PiotroskiCFO/Assets > ROA
      Gross Margin Change YoY25.4% -> 66.1%
      ✓PiotroskiImproved YoY
      Pre-Tax Income / Revenue-113.5%
      ✗Dreman>= 8%
      Net Income / Shareholders' Equity-120.6%
      ✗Dreman> 12%
      Margin of SafetyP/B=1446.9x
      ✗PabraiP/B < 1.5 or P/E < 15
      Return on Equity-19.0% (3-yr avg)
      ✗AkreROE > 20% (3-year avg)
      Discount to Intrinsic ValueN/A (negative normalized EPS)
      ✗Marks>= 20% below intrinsic value
      Positive Net Income Frequency3/10 years positive
      ✗MarksPositive net income in >= 7 of last 10 years
      Operating Income / Revenue-138.6%
      ✗Ackman>= 15%
      Net Income / Shareholders Equity-120.6%
      ✗Ackman>= 15%
      5-Year EPS CAGR
      ✗Templeton> 0% (5-year EPS CAGR)
      Operating Margin Trend-4.8% (2019) -> -138.6% (2021)
      ✗TempletonNon-negative operating-margin trend over 3 years
      Revenue growth vs. gross and operating margin trendgross margin 15.1% -> 66.1%, operating margin -4.8% -> -138.6%
      ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
      Net income / market capitalization-0.08%; #3220/6340 (top 50.8%)
      ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
      Gross profit / total assets+5.83%; #3066/3702 (top 82.8%)
      ✗AsnessTop 30% of eligible cross-section
      Net income / positive book equity-120.57%; #4679/5226 (top 89.5%)
      ✗AsnessTop 30% of eligible cross-section
      Negative 5-year standard deviation of ROA-5.5852; #5642/5884 (top 95.9%)
      ✗AsnessTop 30% of eligible cross-section
      3-5 Year Diluted EPS CAGR
      ✗Neff7%-20% annualized
      Positive Diluted-EPS Years1/9 years positive
      ✗Schloss>= 70% positive over 5-10 observed years (app rule)
    • Valuation0% pass✗ 28▾

      All 13 investors flag SINC's valuation

      Price / 3-yr avg EPS
      ✗Graham<= 15x
      Price-to-Book Ratio1446.9x
      ✗Graham<= 1.5x
      P/E x P/B
      ✗Graham<= 22.5
      Basic earnings-growth PEG (dividends excluded)
      ✗Lynch< 1.0 (ideally < 0.5)
      EBIT / Enterprise Value-0.1%
      ✗Greenblatt> 10%
      Earnings Yield + ROC AssessmentEY=-0.1%, ROC=-42557.6%
      ✗GreenblattBoth EY > 10% and ROC > 25%
      Price / EPS
      ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
      Price / (CFO / Shares)2062.9x
      ✗Dreman< 8x
      Price / Book Value per Share1446.9x
      ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
      Valuation ReasonablenessOE Yield=-0.1%
      ✗MungerP/E < 25 or Owner Earnings Yield > 5%
      P/E or FCF YieldFCF Yield=0.0%
      ✗PabraiP/E < 15 or FCF Yield > 10%
      P/B or P/E vs. Historical AverageP/B=1446.9x
      ✗MarksP/E < 15 or P/B < 2.0
      Discount to Intrinsic ValueN/A (negative normalized EPS)
      ✗Marks>= 20% below intrinsic value
      Price / FCF per Share2062.9x
      ✗Ackman<= 25
      Price vs. Trailing Low370% of trailing low ($0.27)
      ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
      Net income / market capitalization-0.08%; #3220/6340 (top 50.8%)
      ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
      Positive book equity / market capitalization+0.0006; #5244/6449 (top 81.3%)
      ✗AsnessTop 30% of eligible cross-section
      Price / Diluted EPS
      ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
      (EPS CAGR % + Dividend Yield %) / P/E
      ✗Neff> 0.7 (Neff's published traditional edge)
      Price / Tangible Book Value per Share1446.87x
      ✗SchlossP/TBV <= 1.00x (app cutoff)
      Book Value per Share Change
      ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
      Revenue / market capitalization+0.0008; #5030/5247 (top 95.9%)
      ✗OshaughnessyTop 10% of eligible cross-section
      (Operating cash flow - capex) / market capitalization+0.04%; #2528/4519 (top 55.9%)
      ✗OshaughnessyTop 10% of eligible cross-section
      Trailing six-month price return through the evaluation date-41.18%; #4847/6202 (top 78.2%)
      ✗OshaughnessyTop 10% of eligible cross-section
    • Growth0% pass✓ 1✗ 12▾

      No clean pass — all 8 investors flag at least one growth criterion

      EPS Growth (3-yr avg, 10-yr window)
      ✗Graham>= 33% growth
      Basic earnings-growth PEG (dividends excluded)
      ✗Lynch< 1.0 (ideally < 0.5)
      3-5 Year EPS CAGR
      ✗Lynch15-30% (Fast Grower); > 0% to pass
      Inventory Growth vs Revenue GrowthN/A (no inventory)
      ✓LynchInventory growth < Revenue growth
      EPS Growth Direction
      ✗DremanPositive over recent years
      EPS CAGR
      ✗Dreman> 5% annualized
      Positive Net Income Frequency3/10 years positive
      ✗MarksPositive net income in >= 7 of last 10 years
      3yr Median Revenue Growth-56.5%
      ✗Ackman>= 5%
      Positive EPS Growth Frequency
      ✗AckmanPositive EPS growth in >= 3 of last 5 years
      5-Year EPS CAGR
      ✗Templeton> 0% (5-year EPS CAGR)
      Revenue growth vs. gross and operating margin trendgross margin 15.1% -> 66.1%, operating margin -4.8% -> -138.6%
      ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
      5-year Revenue CAGR-41.4%
      ✗SleepCAGR > 7%
      3-5 Year Diluted EPS CAGR
      ✗Neff7%-20% annualized
    • Efficiency0% pass✗ 11▾

      All 8 investors flag SINC's efficiency

      Current Ratio0.78
      ✗Graham>= 2.0
      ROIC (3-5 yr avg)-180.2%
      ✗Buffett> 10%
      ROIC - WACC-190.2%
      ✗BuffettPositive (WACC = 10%)
      EBIT / (NWC + Net Fixed Assets)-42557.6%
      ✗Greenblatt> 25%
      Current Ratio Change YoY0.94 -> 0.78
      ✗PiotroskiIncreased YoY
      Revenue / Total Assets Change YoY0.61x -> 0.09x
      ✗PiotroskiImproved YoY
      Current Assets / Current Liabilities0.78
      ✗Dreman> 1.5
      Return on Invested Capital-68.9%
      ✗Munger> 15%
      ROIC (high and growing)FY2019: ROIC=-16.6%; FY2020: ROIC=32.5%; FY2021: ROIC=-68.9%
      ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
      Reinvestment Rate x ROICN/A (non-positive net income)
      ✗AkreReinvestment Rate * ROIC > 10%
      ROIC (5-year)1/4 years above 12% (latest -68.9%)
      ✗SleepROIC > 12% in a majority of years
    • Verdicts6% pass✓ 1✗ 15▾

      Split decision: 14 FAIL · 1 PASS · 1 NEUTRAL

      Overall verdict
      ✗GrahamFAIL (0/9)✗BuffettFAIL (2/9)✗LynchFAIL (2/7)✗GreenblattRank #2452✓PiotroskiPASS (F-Score 5)✗DremanFAIL (0/11)✗MungerFAIL (0/4)✗PabraiFAIL (0/3)✗AkreFAIL (1/6)✗MarksFAIL (0/5)✗AckmanFAIL (2/9)✗TempletonFAIL (2/8)✗SleepFAIL (2/6)✗AsnessFAIL (Rank #2360/2370 (Top 99.6%))✗NeffFAIL (1/6)✗SchlossFAIL (1/7)•OshaughnessyNEUTRAL (Not ranked)
    • Cash Flow20% pass✓ 3✗ 9▾

      8 of 10 flag SINC's cash flow — Buffett, Lynch, Dreman +5 more

      Free Cash Flow Proxy$-0.1M
      ✗BuffettPositive and growing
      FCF Positive and Growing$0.0M
      ✗LynchPositive and growing
      Operating Cash Flow$0.0M
      ✓PiotroskiCFO > 0
      (CFO / Total Assets) vs ROACFO/Assets=5.00%, ROA=-8.60%
      ✓PiotroskiCFO/Assets > ROA
      Price / (CFO / Shares)2062.9x
      ✗Dreman< 8x
      P/E or FCF YieldFCF Yield=0.0%
      ✗PabraiP/E < 15 or FCF Yield > 10%
      FCF Positive3/10 years FCF positive
      ✗MarksPositive FCF in majority of recent years
      (OCF - CapEx) / Market Cap0.0%
      ✗Ackman>= 4%
      Price / FCF per Share2062.9x
      ✗Ackman<= 25
      Positive Operating Cash Flow frequency3/10 years positive
      ✗SleepPositive OCF in >= 70% of available years
      Operating Cash Flow - Capital Expenditures$0.0M
      ✓Neff> $0 (app proxy for a strong fundamental case)
      (Operating cash flow - capex) / market capitalization+0.04%; #2528/4519 (top 55.9%)
      ✗OshaughnessyTop 10% of eligible cross-section
    • Debt & Leverage25% pass✓ 5✗ 10▾

      9 of 12 flag SINC's debt & leverage — Graham, Buffett, Lynch +6 more

      Total Debt / Shareholders' Equity0.97
      ✗Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
      LT Debt vs Net Current AssetsLT Debt $0.0M vs NCA $-0.1M
      ✗GrahamLT Debt <= Net Current Assets
      Debt/Equity & Interest CoverageD/E: 0.97, IC: -14.6x
      ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
      Total Debt / Equity0.97
      ✗Lynch< 0.33
      Cash - Long-term Debt$0.0M
      ✓LynchPositive preferred
      LT Debt / Total Assets Change7.68% -> 0.00%
      ✓PiotroskiDecreased YoY
      Current Assets / Current Liabilities0.78
      ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
      Debt Levels0.97
      ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
      Interest Coverage & Debt/EBITDAIC=-14.6x, D/EBITDA=N/A
      ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
      Total Debt / Shareholders Equity0.97
      ✓Ackman<= 1.0
      Negative debt-to-equity (higher means less debt)-0.9663; #3189/4210 (top 75.7%)
      ✗AsnessTop 30% of eligible cross-section

    Business & financials

    Financial snapshot: annual FY 2021. Current investor scores may use newer quarterly data.

    Company Profile

    Industry: Chemicals
    SIC Sector: Chemicals & Pharmaceuticals
    Size: Micro Cap($80.8M)
    Revenue: $62968.00-87.0% YoY
    Net Income: $-61326.00-171.7% YoY

    Financial Snapshot

    Operating Margin-138.6%
    Return on Equity-120.6%
    Debt / Equity0.97
    Current Ratio0.78
    Shares Retired0.0% / 0.0% 2y

    Shareholder Return

    Fiscal 2021

    Retired 0.0% of shares last year, 0.0% over two.

    Buybacks
    —
    Dividends
    —

    Company Financials

    Latest TTM and quarters alongside annual years

    TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

    MetricFY 2021
    Sources
    • 10-K · 2022-03-30
    FY 2020
    Sources
    • 10-K · 2021-09-14
    FY 2019
    Sources
    • 10-K · 2021-09-14
    FY 2018
    Sources
    • 10-K · 2021-08-25
    FY 2017
    Sources
    • 10-K · 2018-04-17
    Market Cap$80.8Mcurrent$9.3Test.$7.4Test.$21657.2Test.$9430.3Test.
    Revenue$63.0K↓87%$482.6K↓29%$677.5K↓57%$1.6M↓28%$2.2M
    Operating Income-$87.2K↓218%$74.2K↑329%-$32.4K↑91%-$361.5K↑86%-$2.6M
    Net Income-$61.3K↓172%$85.6K↑832%-$11.7K↓102%$761.8K↑119%-$4.0M
    EPS (Diluted)--$0.00$0.00↓100%$0.02↑125%$-0.08
    Gross Margin66.1%↑160%25.4%↑68%15.1%↑176%5.5%↓41%9.3%
    Operating Margin-138.6%↓1001%15.4%↑422%-4.8%↑79%-23.2%↑81%-120.4%
    ROE-120.6%↓236%88.9%↑451%-25.3%↓100%13450.0%↑6947%190.9%
    Total Debt$49.1K↓42%$84.4K↓22%$108.3K↓18%$131.3K↑82%$72.3K
    Shareholders' Equity$50.9K↓47%$96.3K↑109%$46.1K↑715%$5.7K↑100%-$2.1M
    Current Ratio0.78↓16%0.94↑16%0.81↑18%0.68↑764%0.08
    Debt / Equity0.97↑10%0.88↓63%2.35↓90%23.18↑67154%-0.03
    Operating Cash Flow$35.7K↓85%$236.7K↑146%$96.2K↑115%-$636.4K↓929%-$61.9K
    Free Cash Flow$35.7K↓85%$236.7K↑146%$96.2K↑115%-$636.4K↓849%-$67.1K

    Score history

    Historical Score Timeline

    Industry peers

    Industry Peers

    Similar companies in Chemicals

    SINC vs Peers — Financial Grading

    Revenue$62968.00Bottom 25%
    Net Income$-61326.00Bottom 25%
    ROE-120.6%Bottom 25%
    D/E0.97Bottom 25%
    Op. Margin-138.6%Bottom 25%
    Curr. Ratio0.78Bottom 25%
    CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
    EIDP, Inc.CTA-PB$46.8B$54.21——————2/95/92/70/3F-Score 14/11
    CF Industries Holdings, Inc.CF$18.3B$125.09$7.1B$1.8B37.2%0.6632.5%3.373/94/95/73/3F-Score 88/11
    RPM INTERNATIONAL INC/DE/RPM$13.2B$103.73$7.9B$661.4M20.0%0.77—1.683/92/93/71/3F-Score 67/11
    Element Solutions IncESI$8.0B$33.08$2.6B$190.8M7.1%0.6113.4%3.682/92/91/71/3F-Score 56/11
    NEWMARKET CORPNEU$6.5B$709.19$2.7B$418.7M23.5%0.5020.0%2.534/96/92/71/3F-Score 55/11
    HEXCEL CORP /DE/HXL$6.0B$79.46$1.9B$109.4M8.7%0.799.1%2.262/92/93/70/3F-Score 64/11
    ICL Group Ltd.ICL$5.8B$4.52$7.2B$226.0M3.8%0.468.1%1.335/94/92/70/3F-Score 45/11
    BALCHEM CORPBCPC$5.5B$173.14$1.0B$154.8M12.3%0.1320.2%2.072/94/92/71/3F-Score 95/11